Home/Filings/4/0001209191-23-026998
4//SEC Filing

Seth Alpna 4

Accession 0001209191-23-026998

CIK 0001664710other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 4:45 PM ET

Size

5.3 KB

Accession

0001209191-23-026998

Insider Transaction Report

Form 4
Period: 2023-05-01
Seth Alpna
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-05-01+20,00020,000 total
    Exercise: $46.07Exp: 2033-04-30Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]One-twelfth (1/12th) of the shares subject to the option shall vest in equal quarterly installments commencing on August 1, 2023, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001721020

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:45 PM ET
Size
5.3 KB